BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17964914)

  • 1. Obesity and the polycystic ovary syndrome.
    Magnotti M; Futterweit W
    Med Clin North Am; 2007 Nov; 91(6):1151-68, ix-x. PubMed ID: 17964914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson J; Millward A; Stenhouse E; Pinkney J
    Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M; Vick MR
    P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E
    Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovary syndrome in post-menopausal women--marker of the metabolic syndrome.
    Margolin E; Zhornitzki T; Kopernik G; Kogan S; Schattner A; Knobler H
    Maturitas; 2005 Apr; 50(4):331-6. PubMed ID: 15780534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA; Wickham EP; Nestler JE
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome].
    Benítez R; Sir-Petermann T; Palomino A; Angel B; Maliqueo M; Pérez F; Calvillán M
    Rev Med Chil; 2001 Jul; 129(7):707-12. PubMed ID: 11552437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
    Diamanti-Kandarakis E; Christakou C; Kandarakis H
    Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
    Cattrall FR; Healy DL
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):803-12. PubMed ID: 15380148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY; Wild RA
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women.
    Talbott EO; Zborowski JV; Rager JR; Kip KE; Xu X; Orchard TJ
    J Womens Health (Larchmt); 2007 Mar; 16(2):191-7. PubMed ID: 17388735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes.
    Amini M; Horri N; Farmani M; Haghighi S; Sattari G; Pornaghshband Z; Aminorroaya A
    Gynecol Endocrinol; 2008 Aug; 24(8):423-7. PubMed ID: 18850378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.
    Lakhani K; Prelevic GM; Seifalian AM; Atiomo WU; Hardiman P
    J Obstet Gynaecol; 2004 Sep; 24(6):613-21. PubMed ID: 16147598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P; Raingeard I; Renard E; Bringer J
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.